Stroke Care Delivery in Institutions Participating in the Registry of the Canadian Stroke Network
- 1 July 2004
- journal article
- research article
- Published by Wolters Kluwer Health in Stroke
- Vol. 35 (7) , 1756-1762
- https://doi.org/10.1161/01.str.0000130423.50191.9f
Abstract
Background and Purpose— Guidelines and performance indicators have been established for acute stroke care. However, little is known about the process of stroke care delivery in Canada. Methods— The Registry of the Canadian Stroke Network (RCSN) captured detailed clinical data on patients with stroke and transient ischemic attack seen at 21 acute care institutions across Canada. Data from phase 1 of the RCSN (June 2001 to February 2002) were used to determine the use of evidence-based acute stroke care interventions in participating institutions. Results— Overall, 4439 patients were seen during the study time frame and 1701 (38%) consented to full data collection. Thirty-one percent received care on a stroke unit or from a mobile stroke team. Among patients with ischemic stroke, 7% received thrombolysis, 80% underwent carotid imaging, 89% received antithrombotic agents, and 54% of those with atrial fibrillation received warfarin. There were significant intersite variations in the delivery of all of these interventions except for the use of antithrombotic agents, and these persisted after adjustment for age, sex, stroke type, and other comorbid conditions. Conclusions— Patients in institutions participating in the RCSN received high-quality stroke care based on a number of performance measures. However, gaps exist in the provision of other elements of stroke care, particularly organized inpatient stroke care and warfarin for atrial fibrillation. Future research should explore explanations for these findings and focus on solutions to deficiencies in care.Keywords
This publication has 20 references indexed in Scilit:
- Relationship Between Process and Outcome in Stroke CareStroke, 2003
- Guideline Compliance Improves Stroke OutcomeStroke, 2002
- Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patientsBMJ, 2002
- Recommendations for the Establishment of Primary Stroke CentersJAMA, 2000
- Tissue Plasminogen Activator for Acute Ischemic StrokeNew England Journal of Medicine, 1995
- Secondary prevention in non-rheumatic atrial fibrillation after transient ischaemic attack or minor strokeThe Lancet, 1993
- Beneficial Effect of Carotid Endarterectomy in Symptomatic Patients with High-Grade Carotid StenosisNew England Journal of Medicine, 1991
- Classification and natural history of clinically identifiable subtypes of cerebral infarctionPublished by Elsevier ,1991
- MRC European Carotid Surgery Trial: interim results for symptomatic patients with severe (70-99%) or with mild (0-29%) carotid stenosisThe Lancet, 1991
- A new method of classifying prognostic comorbidity in longitudinal studies: Development and validationJournal of Chronic Diseases, 1987